Contact
Please use this form to send email to PR contact of this press release:
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
TO:
Please use this form to send email to PR contact of this press release:
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
TO: